Articles

Independent intelligence on the US medical-aesthetics industry.

Regulation

New York Med Spa Laws: Ownership, Licenses and Procedures
A service-led map of professional-practice ownership, clinician roles, cosmetic injections, laser hair removal and office-based surgery. (Published August 8, 2026)
Florida Med Spa Rules: Licenses, Supervision and Lasers
An activity-led map of practitioner licenses, injection roles, physician supervision, laser hair removal, clinic licensing and office-surgery boundaries. (Published July 30, 2026)
Texas Med Spa Laws: Ownership, Delegation and Lasers
How Texas rules divide ownership, physician delegation, injection orders, prescriptive authority and laser hair removal. (Published August 13, 2026)
Who Actually Regulates Medical Spas?
How federal agencies, state boards and professional rules divide the job — and where clinic owners should look first. (Published July 16, 2026)
Who Can Own a Med Spa in California?
California treats a med spa like a medical business — not a beauty salon. What that means for ownership, clinicians and public records. (Published July 17, 2026)

Are Med Spas Profitable? A Break-Even Model
A transparent monthly model for testing revenue mix, labor, supplies, fixed costs, capacity and cash timing—without inventing a national profit margin. (Published August 8, 2026)
How to Open a Med Spa: A State-First Planning Guide
A state-first sequence for mapping services, ownership, licensed roles, premises, devices, startup costs and launch dependencies. (Published July 28, 2026)
How Much Does It Cost to Open a Med Spa?
Startup costs broken down transparently: premises, licensing, devices, staffing, marketing and working capital. Sourced benchmarks—no invented national average. (Published July 21, 2026)
How Med Spas Actually Make Money
Treatments bring people in. Retention, memberships and disciplined operations decide whether the business works. (Published July 17, 2026)
What Public Data Reveals About Med Spa Web Presence
A 20-clinic dataset reveals patterns in web-presence churn, provider transparency and data reliability. (Published July 17, 2026)

Botox vs. Fillers: Differences, Uses and Risks
A source-led guide to different mechanisms, FDA-labeled context, timing, material risks and urgent warning signs. (Published August 12, 2026)
Exosome Treatments: What FDA Status and Human Evidence Show
FDA status, early human skin studies and the limits of applying evidence from one formulation, route or procedure to another. (Published August 8, 2026)
Botox vs. Dysport vs. Xeomin vs. Daxxify: Why Units Do Not Compare
Why FDA-labeled potency units cannot be converted—and why separate product trials do not establish a simple winner. (Published July 29, 2026)
What FDA Adverse-Event Data Can—and Cannot—Show
How to search FDA device reports—and why MAUDE data cannot prove causation, incidence or comparative device safety. (Published July 22, 2026)
FDA Cleared Is Not FDA Approved: What Clinics Need to Know
Two phrases appear constantly in device marketing. They do not mean the same thing — and clinics should know the difference. (Published July 17, 2026)

Med Spa EMR vs. CRM vs. Practice Management Software
A 12-requirement comparison of clinical records, CRM workflows and practice operations, with security, integration and export tests. (Published August 8, 2026)
Med Spa Memberships vs. Packages: A Break-Even Model
Compare recurring memberships and prepaid packages across cash timing, redemption costs, discounts, capacity and cancellations. (Published July 31, 2026)
Buy vs. Lease Med Spa Equipment: A Cost Model
Compare buying, financing and leasing across cash timing, service costs, utilization, residual value and exit risk. (Published July 24, 2026)
The Software Stack Behind a Modern Med Spa
Booking is only the beginning. Modern practices rely on connected systems for retention, memberships, financing, reputation and patient communication. (Published July 17, 2026)